NEW YORK (TheStreet) -- IPC The Hospitalist Company (Nasdaq:IPCM) hit a new 52-week high Tuesday as it traded at $41.25 compared with its previous 52-Week high of $41.23. IPC The Hospitalist is changing hands at $41.25 with 26,088 shares traded as of 11:01 a.m. ET. Average volume has been 94,700 shares over the past 30 days. IPC The Hospitalist has a market cap of $652.3 million and is part of the health care sector and health services industry. Shares are up 4.6% year to date as of the close of trading on Monday. IPC The Hospitalist Company, Inc., a physician group practice company, provides hospitalist services in the United States. The company has a P/E ratio of 29.3, above the average health services industry P/E ratio of 29.1 and above the S&P 500 P/E ratio of 21.8. TheStreet Ratings rates IPC The Hospitalist as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, impressive record of earnings per share growth, compelling growth in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. You can view the full IPC The Hospitalist Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center.
Latest Headlines about IPCM
Latest from TheStreet Wire
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV